Efficacy of INTORUS as a Therapeutic Tool in Motor Intervention in Patients at Aspace Centres in the Province of Cáceres

NCT ID: NCT05753800

Last Updated: 2023-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this Clinical Trial is to verify the effectiveness of the use of the Intorus device in the motor intervention in patients with cerebral palsy and related syndromes. The main question it aims to answer is:

Does the use of the Intorus tool manage to improve the mobility of upper limbs (MMSS) in patients with infantile cerebral palsy to increase their performance in activities of daily living? A total of approximately 50 users will participate in the study. Participants will be divided into two groups randomly. The control group will receive an intervention treatment at the motor level in the traditional way, following the protocols established in the center, and the intervention group will receive an intervention treatment at the motor level with the INTORUS device.

Randomization will be carried out using the Oxford Minimization and Randomization software.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The intervention program will take place during the Occupational Therapy sessions and will be carried out by the center's occupational therapists. These sessions must be carried out in a quiet environment, without distractions so that the user can concentrate on carrying out the activities. It is important that the patient attends the sessions in comfortable, sleeveless clothing, to allow the tool to slide smoothly through their upper limbs.

Each session will consist of several exercises with their corresponding rest breaks.

EVALUATION

The evaluations will be carried out prior to the start of treatment, at 20 weeks of treatment and at 40 weeks of treatment once the intervention program has concluded.

The tools used to carry out the evaluation will be:

* Questionnaire of sociodemographic variables
* Goniometric

* Shoulder joint: abduction-adduction, flexion-extension, external-internal rotation.
* Elbow joint: flexion-extension, pronation-supination.
* Wrist joint: flexion-extension, radial-ulnar deviation.
* Articulation of the thumb: abduction-adduction, flexion-extension, opposition.
* Articulation of the fingers: flexion-extension, abduction-adduction.
* Gross Motor Function Classification
* Assessment of a functional gesture
* Satisfaction questionnaire for professionals The evaluations will be carried out by a professional external to the center to avoid bias.

Once the intervention period is over, a questionnaire will be passed to the professionals participating in the study to assess the usefulness of the device, the degree of satisfaction with it and the usefulness of the therapies applied.

TIMELINE The intervention consists of 40 treatment sessions lasting 45 minutes each with a frequency of 2 days a week in which the intervention program described above will be developed.

Previously, the participants will receive a "session 0" in which they will carry out a first contact with the device.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy Motor Disorders Motor Activity

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

cerebral palsy motor activity motor disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

This group receives motor intervention sessions with the Intorus device

Group Type EXPERIMENTAL

INTORUS

Intervention Type DEVICE

Motor intervention protocol with Intorus consisting of a series of exercises of progressive difficulty

Control group

This group receives no motor intervention sessions with the Intorus device

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

INTORUS

Motor intervention protocol with Intorus consisting of a series of exercises of progressive difficulty

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Users with infantile cerebral palsy and/or related syndromes.
* Ages between 4 and 18 years.
* Motor disability.
* Affectation in the mobility of upper limbs.
* Informed consent signed by parents/guardians.

Exclusion Criteria

* Patients with another type of pathology not related to cerebral palsy.
* Under 4 years and over 18 years.
Minimum Eligible Age

4 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Extremadura

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Blanca González Sanchez

doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Blanca González Sánchez, Doctor

Role: PRINCIPAL_INVESTIGATOR

Universidad de Extremadura

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Blanca González Sánchez

Cáceres, Caceres, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IPC.2023

Identifier Type: -

Identifier Source: org_study_id